136 related articles for article (PubMed ID: 11445245)
1. GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity.
Ito T; Igarashi H; Pradhan TK; Hou W; Mantey SA; Taylor JE; Murphy WA; Coy DH; Jensen RT
Peptides; 2001 Jul; 22(7):1139-51. PubMed ID: 11445245
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.
Igarashi H; Ito T; Hou W; Mantey SA; Pradhan TK; Ulrich CD; Hocart SJ; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Apr; 301(1):37-50. PubMed ID: 11907155
[TBL] [Abstract][Full Text] [Related]
4. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
5. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.
Dickson L; Aramori I; McCulloch J; Sharkey J; Finlayson K
Neuropharmacology; 2006 Nov; 51(6):1086-98. PubMed ID: 16930633
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
9. Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line.
Lema-Kisoka R; Hayez N; Langer I; Robberecht P; Sariban E; Delporte C
Peptides; 2001 Dec; 22(12):2155-62. PubMed ID: 11786204
[TBL] [Abstract][Full Text] [Related]
10. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
Mol Pharmacol; 1999 Dec; 56(6):1280-7. PubMed ID: 10570056
[TBL] [Abstract][Full Text] [Related]
11. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
Reed HE; Meyer-Spasche A; Cutler DJ; Coen CW; Piggins HD
Eur J Neurosci; 2001 Feb; 13(4):839-43. PubMed ID: 11207820
[TBL] [Abstract][Full Text] [Related]
13. Development of high affinity selective VIP1 receptor agonists.
Gourlet P; Vandermeers A; Vertongen P; Rathe J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Peptides; 1997; 18(10):1539-45. PubMed ID: 9437714
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and functional expression of a VIP-specific receptor.
Zhou H; Huang J; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G728-34. PubMed ID: 16959956
[TBL] [Abstract][Full Text] [Related]
16. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
Perret J; Vertongen P; Solano RM; Langer I; Cnudde J; Robberecht P; Waelbroeck M
Br J Pharmacol; 2002 Aug; 136(7):1042-8. PubMed ID: 12145104
[TBL] [Abstract][Full Text] [Related]
17. Identification of a VIP-specific receptor in guinea pig tenia coli.
Teng BQ; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
[TBL] [Abstract][Full Text] [Related]
18. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
Montpetit CJ; Shahsavarani A; Perry SF
J Exp Biol; 2003 Jun; 206(Pt 11):1917-27. PubMed ID: 12728013
[TBL] [Abstract][Full Text] [Related]
19. The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues.
Dubreuil P; Brazeau P; Moreau S; Farmer C; Coy D; Abribat T
Growth Horm IGF Res; 2001 Jun; 11(3):173-86. PubMed ID: 11735232
[TBL] [Abstract][Full Text] [Related]
20. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J
Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
